Antimicrobial Resistance and Therapy in Intensive Care Unit

Pablo Vidal-Cortés, Borja Suberviola-Cañas and David Andaluz-Ojeda

Intensive Care Unit; Multidrug-resistant bacteria 2; Empirical antimicrobial therapy; TDM; Pseudomonas aeruginosa; Cefiderocol; Acinetobacter baumanii; Stenotrophomonas maltophilia;

This Reprint brings together cutting-edge contributions that address the acute and evolving challenge of antimicrobial resistance in the intensive care setting. Critically ill patients in Intensive Care Units (ICUs) face a disproportionate burden of infections caused by multidrug-resistant organisms, demanding a rigorous appraisal of both epidemiological trends and therapeutic strategies. In this collection we highlight three interconnected domains: (1) the dynamic epidemiology of key pathogens

journal Antibiotics

2026

file

pdf

978-3-7258-6311-2

https://doi.org/10.3390/books978-3-7258-6311-2

Eng

https://creativecommons.org/licenses/by-nc-nd/4.0/

Pharmacy